Literature DB >> 9633032

Service-level costing of drug abuse treatment.

D W Anderson1, B J Bowland, W S Cartwright, G Bassin.   

Abstract

This paper presents a methodology for estimating costs of delivering specific substance abuse treatment services. Data collected from 13 programs indicate that the mean cost of residential treatment is $2,773 per patient per month, and outpatient treatment costs average $636 per patient per month. Data are presented on the cost patient per month for individual treatment and nontreatment services, average number of services, cost per unit of service, and intensity of services. In addition to their application to insurance benefit cost estimation, these data illustrate the costing of best-practice adolescent treatment consistent with a Center of Substance Abuse Treatment (CSAT) Treatment Improvement Protocol. In the emerging policy environment, detailed cost estimates like these will aid the design of cost-effective treatment programs, and serve the development of the substance abuse benefit in a health care reform insurance package.

Entities:  

Mesh:

Year:  1998        PMID: 9633032     DOI: 10.1016/s0740-5472(97)00189-x

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  18 in total

Review 1.  The cost-effectiveness of substance abuse treatment.

Authors:  P G Barnett
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

2.  Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.

Authors:  Michael T French; Helena J Salomé; Jody L Sindelar; A Thomas McLellan
Journal:  Health Serv Res       Date:  2002-04       Impact factor: 3.402

3.  The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement.

Authors:  Michael T French; Ioana Popovici; Lauren Tapsell
Journal:  J Subst Abuse Treat       Date:  2008-02-21

4.  Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients.

Authors:  Emlyn S Jones; Brent A Moore; Jody L Sindelar; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2008-09-19       Impact factor: 4.492

5.  Costs of promoting cancer screening: Evidence from CDC's Colorectal Cancer Control Program (CRCCP).

Authors:  Florence K L Tangka; Sujha Subramanian; Sonja Hoover; Janet Royalty; Kristy Joseph; Amy DeGroff; Djenaba Joseph; Sajal Chattopadhyay
Journal:  Eval Program Plann       Date:  2016-12-12

6.  Recommendations From the International Colorectal Cancer Screening Network on the Evaluation of the Cost of Screening Programs.

Authors:  Sujha Subramanian; Florence K L Tangka; Sonja Hoover; Marion Nadel; Robert Smith; Wendy Atkin; Julietta Patnick
Journal:  J Public Health Manag Pract       Date:  2016 Sep-Oct

7.  Treatment program operations and costs.

Authors:  Kirk M Broome; Danica K Knight; George W Joe; Patrick M Flynn
Journal:  J Subst Abuse Treat       Date:  2011-12-05

8.  Deriving costs of service use among an urban homeless population.

Authors:  Brian S Fuehrlein; Alexander J Cowell; David E Pollio; Lori Y Cupps; Margaret E Balfour; Carol S North
Journal:  J Subst Abuse Treat       Date:  2013-12-21

9.  The cost of treating addiction from the client's perspective: results from a multi-modality application of the Client DATCAP.

Authors:  Kathryn E McCollister; Michael T French; Jeffrey M Pyne; Brenda Booth; Richard Rapp; Carey Carr
Journal:  Drug Alcohol Depend       Date:  2009-07-01       Impact factor: 4.492

10.  Research priorities for economic analyses of prevention: current issues and future directions.

Authors:  D Max Crowley; Laura Griner Hill; Margaret R Kuklinski; Damon E Jones
Journal:  Prev Sci       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.